Ladd Atkins, DO
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (42.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Kerecis Limited at 46.3% of the total. Reporting peaked in 2023 at $4,033 and has fallen 96.5% since, to $142 in 2025.
Across 150 payments — averaging $67.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$5K
- AbbVie$3K
- Medtronic$406
- Next Science LLC$240
- Organogenesis Inc.$232
- Galderma Laboratories, L.p.$199
- plus $1K from 23 others
What the payments were for
- Travel & lodging$4,28842%
- Food & beverage$3,85138%
- Gifts$2,05420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 5 | $4,723 |
| AbbVie(2 entities) | 65 | $3,142 |
| Medtronic(2 entities) | 9 | $406 |
| Next Science LLC | 3 | $240 |
| Organogenesis Inc. | 2 | $232 |
| Galderma Laboratories, L.p. | 7 | $199 |
| Bard Peripheral Vascular, Inc. | 5 | $153 |
| Smith+Nephew | 4 | $138 |
| Boston Scientific | 6 | $122 |
| Lumenis, Inc | 1 | $111 |
| Averitas Pharma Inc. | 5 | $111 |
| Novo Nordisk | 7 | $98 |
| Sentynl Therapeutics, Inc. | 6 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $68 |
| Antares Pharma, Inc. | 4 | $56 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Integra Lifesciences Corporation | 1 | $36 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Bausch & Lomb Americas Inc. | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Si-bone, Inc. | 1 | $19 |
| Avanos Medical | 1 | $19 |
| GRT US Holding, Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Polynovo North America LLC | 1 | $15 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$11,832
- Kerecis Omega3 Marigen$6,887
- Kerecis Omega3 GraftGuide$4,680
- NATRELLE$2,054
- PuraPly$232
- Xperience$229
- BlastX$229
- Versaseal$174
- Stravix$125
- Grafix$125
- GrafixPL$125
- BOTOX$123
- SurgX$121
How this compares
$10,194 in reported general payments places this provider in the 85th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 62 | $65,526 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,768 | $57,955 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 727 | $23,560 |
| BelbucaBuprenorphine Hcl | 32 | $21,738 |
| Oxycodone Hcl | 845 | $15,040 |
| Buprenorphine | 34 | $10,391 |
| Hysingla ErHydrocodone Bitartrate | 15 | $7,722 |
| Xtampza ErOxycodone Myristate | 26 | $5,918 |
| MovantikNaloxegol Oxalate | 11 | $4,583 |
| Pregabalin | 267 | $3,919 |
| Naloxone Hcl | 58 | $3,699 |
| Morphine Sulfate ErMorphine Sulfate | 102 | $3,019 |
| Cyclobenzaprine Hcl | 219 | $2,938 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $2,330 |
| Gabapentin | 184 | $2,229 |
Paid to pharmacies, not to this prescriber.
Other surgery in Tulsa
- Craig JohnsonTulsa$573K
- Eugene DickensTulsa$456K
- William JenningsTulsa$412K
- Bryce MurrayTulsa$152K
- Steven FeherTulsa$50K
- Samuel PangburnTulsa$50K
- Jared LepleyTulsa$48K
- Ty KirkpatrickTulsa$28K
- John KingTulsa$24K
- Michael ThomasTulsa$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.